
Cabot Energy CEO Keith Bush announced the results of the winter work programme in Alberta today, describing them as 'better than expected'. He was keen to emphasise the successful use of 3D seismic t...

Dr Vladislav Sandler, Co-Founder and CEO of HemoGenyx Pharmaceuticals #LSE #HEMO discusses two major announcements with London South East. First data results show that CDX antibodies have b...

#ANGS is to form a joint venture with Cuadrilla Resources and Lucas Energy. Angus is to take a 25% stake in the Weald Balcombe licence for £4M and becomes the operating partner. This is funde...

TransGlobe Energy announced a 27% increase in production last November, a nicely timed increase as the oil price rises. Randy Neely, TransGlobe’s President, fills us in on what else has been...

Frontera Resources Chief Executive Zaza Mamulaishvili confirmed to London South East that a new drilling programme begins tonight on the Tiribani Field Block 12, in the south west of Georgia close to...

Ascent Resources CEO Colin Hutchinson sets out in detail his strategic approach for the next few years. He believes the Slovenian Environment Agency will grant a permit for a new processing plant to ...

Mike Buck, new CEO of the only AIM-listed Mongolian oil explorer, Petro Matad, told London South East four wells are to be drilled in a 2018 work programme. In a bullish interview he explained tha...

Cabot Energy, listed on AIM as #CAB , have bought the remaining 25% of the oil-producing Canadian assets they operate in Alberta. In effect they become the operator of the field and all revenues ret...

Ranjeet Singh, Director at brokers London Stone Securities, and himself a long term investor, gives us his six monthly market update. Ranjeet discusses his investment trends for 2018 and tell us wher...

#HEMO are a London-listed, US-based biotech company developing two revolutionary blood cancer treatments. CDX antibodies are intended to remove the need for chemo and radiation before a bone mar...

Reabold Resources Co-Chief Executives Stephen Williams and Sachin Oza have just successfully raised 'approximately six million pounds' to invest in their innovative strategy. #RBD have also toda...

Josh Blacher, CFO at Therapix Biosciences, describes how his company are developing a therapeutic approach to obstructive sleep apnea, and in parallel are developing a synthetic cannabinoid-based tab...

Lionel Segard is Chairman & CEO of Quantum Genomics, a French biotech company launched 11 years ago. Quantam are developing 1st in class drugs to treat hypertension and chronic heart failure. ...

Peter Garcia, the CFO at PDL BioPharma explains that in his view, PDL is 'unique'. Located in Lake Tahoe, Nevada, PDL is a publicly traded private equity group listed on Nasdaq: #PDLI . 'PDL allows ...

Erik Kinnman, CEO of Swedish biotech company NeuroVive Pharmaceutical, says that his company are at the forefront of research into mitochondrial medicine, which is the subject of growing interest. ...

Cameron Reynolds, Volition CEO, told London South East he expects to hit significant clinical test milestones in 2018 and to get a CE Mark and to begin selling their colorectal cancer blood test in E...

Peter Molloy, CEO at Race Oncology explains how his business speeds up taking drugs to market. Race look for old drug assets which have been developed and discarded by big pharma companies who chose ...

Heat Biologics is an immunotherapy cancer company based in North Carolina,and listed on Nasdaq: HTBX. Heat develop drugs for non small-cell lung cancer and are in Phase II development trials using a ...

Henrik Simonsen, CFO, Nuevolution explains that his biotech company is listed on the Nasdaq First North Premier Exchange, a Stockholm-based growth stock exchange. Neuvolution have unique tablet-ba...

PRESIDENT ENERGY: Peter Levine, CEO and Chairman, sums up President as 'a growth business on income, profitability and cash'. It is looking to double production from the current 2400 bopd organically...

ASCENT RESOURCES: Chief Executive Colin Hutchinson tells London South East that gas flowed from the Petisovci field in Slovenia to INA in Croatia last Thursday. They expect to be receiving around Eur...

Keith Bush, CEO at Cabot Energy explains why better than expected sidetrack well flow rates auger well for the future potential of their Alberta oil assets. 100 bpd of oil was expected, 680 bpd flowe...

Caspian Sunrise Chairman Clive Carver gives us an in-depth update on exploration and strategy in Kazakhstan. A flow test is to start within days on the 3500 bpd A5 deep well, with Clive 'disappointed...

David Lenigas answers all your investor questions in a long and frank interview with London South East. ...